Privacy Bill In California Could Preview Fights On “Opt Out,” State Preemption
Executive Summary
Pharmaceutical companies and their agents would be required to allow patients to receive drugs even if patients do not consent to disclosure of their medical information under legislation pending in the California state assembly
You may also be interested in...
Lilly Evaluating Audit Committee Responsibilities In Light Of New NYSE Rules
Lilly is evaluating the legal and regulatory oversight responsibilities of its audit committee in light of New York Stock Exchange Corporate Governance Rules
Lilly Evaluating Audit Committee Responsibilities In Light Of New NYSE Rules
Lilly is evaluating the legal and regulatory oversight responsibilities of its audit committee in light of New York Stock Exchange Corporate Governance Rules
Rx “Switch Letter” Investigations Focus On Pharmacy Profit, Disclosure
Retail pharmacies realize a 50% profit margin on drug manufacturer-sponsored "switch letters," a Florida Attorney General investigation suggests